Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Eisen

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|August 21, 2001
The epidemiology of gastroesophageal reflux disease: what we know and what we need to knowG Eisen
Year Book|January 11, 2011
[Not Available]G Eisen
Melanoma Research|August 1, 1996
The control of gene expression in melanocytes and melanomasT G Eisen
Oncology (Williston Park, N.Y.)|February 24, 2001
Thalidomide in solid tumors: the London experienceT G Eisen
Clinical Genitourinary Cancer|October 10, 2006
Adjuvant therapy of renal cell carcinomaTimothy A Yap, Tim G Eisen
Endoscopy|September 29, 2005
ICCE consensus for obscure gastrointestinal bleedingM Pennazio, G Eisen, N Goldfarb, et al.
The Lancet. Oncology|March 21, 2002
The biological treatment of renal-cell carcinoma and melanomaPaul D Nathan, Tim G Eisen
Journal of Allied Health|May 1, 1985
Clinical research: the case study and single-subject designsI S Weiner, R G Eisen
Expert Opinion on Pharmacotherapy|December 4, 2003
Systemic chemotherapy in the treatment of malignant melanomaMarko B Lens, Tim G Eisen
International Journal of Cancer|March 29, 2002
Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effectsKeiran S M Smalley, Tim G Eisen
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|August 21, 2001
The epidemiology of gastroesophageal reflux disease: what we know and what we need to knowG Eisen
Year Book|January 11, 2011
[Not Available]G Eisen
Melanoma Research|August 1, 1996
The control of gene expression in melanocytes and melanomasT G Eisen
Oncology (Williston Park, N.Y.)|February 24, 2001
Thalidomide in solid tumors: the London experienceT G Eisen
Clinical Genitourinary Cancer|October 10, 2006
Adjuvant therapy of renal cell carcinomaTimothy A Yap, Tim G Eisen
Endoscopy|September 29, 2005
ICCE consensus for obscure gastrointestinal bleedingM Pennazio, G Eisen, N Goldfarb, et al.
The Lancet. Oncology|March 21, 2002
The biological treatment of renal-cell carcinoma and melanomaPaul D Nathan, Tim G Eisen
Journal of Allied Health|May 1, 1985
Clinical research: the case study and single-subject designsI S Weiner, R G Eisen
Expert Opinion on Pharmacotherapy|December 4, 2003
Systemic chemotherapy in the treatment of malignant melanomaMarko B Lens, Tim G Eisen
International Journal of Cancer|March 29, 2002
Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effectsKeiran S M Smalley, Tim G Eisen
Pageof 5